IBI-355 / Innovent Biologics - LARVOL DELTA

Safety and Tolerability of IBI355 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Completed | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Dec 2025 ➔ Apr 2025

Trial completion • Trial completion date

Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome (clinicaltrials.gov) - P1 | N=30 | Active, not recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed • Immunology • Sjogren's Syndrome

Safety and Tolerance Study of IBI355 in Health Volunteers (clinicaltrials.gov) - P1 | N=53 | Completed | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Active, not recruiting ➔ Completed

Trial completion

Safety and Tolerability of IBI355 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Active, not recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed

Safety and Tolerability of IBI355 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open

Safety and Tolerance Study of IBI355 in Health Volunteers (clinicaltrials.gov) - P1 | N=53 | Active, not recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Not yet recruiting ➔ Active, not recruiting

Enrollment closed

Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Immunology • Sjogren's Syndrome

Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

New P1 trial • Immunology • Sjogren's Syndrome

Safety and Tolerability of IBI355 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=32 | Not yet recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

New P1 trial

Safety and Tolerance Study of IBI355 in Health Volunteers (clinicaltrials.gov) - P1 | N=53 | Not yet recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

New P1 trial